The Michael J . Fox Foundation
Industry Partners
Biotechnology and pharmaceutical companies play a key role in the Foundation ’ s roadmap strategy to accelerate improved treatments for Parkinson ’ s disease . Their support expands our capability to speed clinical trials , engage the Parkinson ’ s community in research , and bring science closer to a cure . Collectively , these partners contributed more than $ 5 million to our programs in 2017 .
We also extend our gratitude to the 2017 Parkinson ’ s Disease Education Consortium . This alliance of industry partners supports our commitment to furnishing high-quality educational resources for the PD community while preserving our track record of efficiency in stewarding donor-raised contributions for maximum impact on Parkinson ’ s drug development .
Learn more at michaeljfox . org / sponsors .
Abbvie
Acadia Pharmaceuticals *
Acorda Therapeutics
Adamas Pharmaceuticals *
Allergan Amgen Amicus Therapeutics
BIO ( Biotechnology Innovation Organization )
Biogen
Bristol Meyers Squibb
Cellular Dynamics International *
Charles River Laboratories
GlaxoSmithKline Impax Laboratories
Institut de Recherches Internationales Servier
Lundbeck *
Medical Device Innovation Consortium ( MDIC )
Merck and Co
Meso Scale Diagnostics
Pfizer *
Prothena Biosciences *
Regeneron Pharmaceuticals
Sunovion Pharmaceuticals *
Takeda Pharmaceuticals International
UCB United Technologies Voyager Therapeutics
* Parkinson ’ s Disease Education Consortium
18